Yaron Naos
2023
In 2023, Yaron Naos earned a total compensation of $776.4K as Senior Vice President, Operations at Protalix BioTherapeutics, a 46% increase compared to previous year.
Compensation breakdown
| Bonus | $212,367 |
|---|---|
| Option Awards | $133,469 |
| Salary | $216,504 |
| Stock Awards | $129,081 |
| Other | $84,948 |
| Total | $776,369 |
Naos received $216.5K in salary, accounting for 28% of the total pay in 2023.
Naos also received $212.4K in bonus, $133.5K in option awards, $129.1K in stock awards and $84.9K in other compensation.
Rankings
In 2023, Yaron Naos' compensation ranked 1,310th out of 2,320 executives tracked by ExecPay. In other words, Naos earned more than 43.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,310 out of 2,320 | 44th |
Division Manufacturing | 768 out of 1,253 | 39th |
Major group Chemicals And Allied Products | 491 out of 708 | 31st |
Industry group Drugs | 477 out of 679 | 30th |
Industry Biological Products, Except Diagnostic Substances | 129 out of 162 | 20th |
Source: SEC filing on April 29, 2024.
Naos' colleagues
We found two more compensation records of executives who worked with Yaron Naos at Protalix BioTherapeutics in 2023.
News
Protalix BioTherapeutics CEO Dror Bashan's 2023 pay jumps 83% to $2.7M
April 29, 2024
Protalix BioTherapeutics CEO Dror Bashan's 2022 pay jumps 27% to $1.5M
May 18, 2023
Protalix BioTherapeutics CEO Dror Bashan's 2021 pay slips 14% to $1.2M
April 29, 2022
Protalix BioTherapeutics CEO Moshe Manor's 2019 pay slips 14% to $616K
April 15, 2020
Protalix BioTherapeutics CEO Moshe Manor's 2018 pay falls 23% to $718K
April 12, 2019